Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 1121 - 1140 of 1999 results

Assessing Alignment of Sexual Orientation and Sex of Sex Partners Among Men With Primary and Secondary Syphilis, 2022.

Rushmore, Julie ;

Jackson, David A.

January 2026 | Sexually Transmitted Diseases, 2026, v. 53, no. 1

We examined alignment between sex of sex partners and sexual orientation in syphilis case notifications among men in 2022 to inform interpretation of sexual orientation data for notifiable conditions in the National Notifiable Diseases Surveillance System. Observed partial alignment underscores the importance of analyzing appropriate variable(s) fo ...

10/09/2026

Supporting Files

Title : Assessing Alignment of Sexual Orientation and Sex of Sex Partners Among Men With Primary and Secondary Syphilis, 2022. Personal Author(s) : Rushmore, Julie;Jackson, David A.;Grey, Jeremy A.;Torrone, Elizabeth A.;Learner, Emily R.; Published Date : January 2026 Pages in Document : e9-e10 (5 pdf pages) Source : Sexually Transmitted Diseases, 2026, v. 53, no. 1 DOI : https://doi.org/10.1097/OLQ.0000000000002213 Journal Title : Sexually Transmitted Diseases
Rushmore, J., Jackson, D. A., Grey, J. A., Torrone, E. A., & Learner, E. R. (2026). Assessing Alignment of Sexual Orientation and Sex of Sex Partners Among Men With Primary and Secondary Syphilis, 2022. Sexually Transmitted Diseases, 53(1). https://doi.org/10.1097/OLQ.0000000000002213

Rushmore, Julie, David A. Jackson, Jeremy A. Grey, Elizabeth A. Torrone, and Emily R. Learner. "Assessing Alignment of Sexual Orientation and Sex of Sex Partners Among Men With Primary and Secondary Syphilis, 2022." Sexually Transmitted Diseases 53, no. 1 (2026). https://doi.org/10.1097/OLQ.0000000000002213.

Rushmore, Julie, et al. "Assessing Alignment of Sexual Orientation and Sex of Sex Partners Among Men With Primary and Secondary Syphilis, 2022." Sexually Transmitted Diseases, vol. 53, no. 1, 2026. Stacks. https://doi.org/10.1097/OLQ.0000000000002213.
Export RIS Citation Information. TY - Journal Article AU - Rushmore, Julie AU - Jackson, David A. AU - Grey, Jeremy A. AU - Torrone, Elizabeth A. AU - Learner, Emily R. AB - We examined alignment between sex of sex partners and sexual orientation in syphilis case notifications among men in 2022 to inform interpretation of sexual orientation data for notifiable conditions in the National Notifiable Diseases Surveillance System. Observed partial alignment underscores the importance of analyzing appropriate variable(s) for a given intervention. AB - Author manuscript AN - cdc:261288 C4 - PMC12326550 DO - https://doi.org/10.1097/OLQ.0000000000002213 IS - 1 J2 - Sexually Transmitted Diseases KW - Syphilis KW - Male KW - Middle Aged KW - Humans KW - Young Adult KW - Adult KW - Sexual Behavior KW - Sexual Partners KW - SOGI KW - National Notifiable Diseases Surveillance System KW - surveillance KW - syphilis KW - Humans KW - Syphilis KW - Male KW - Sexual Partners KW - Sexual Behavior KW - Adult KW - Middle Aged KW - Young Adult LA - eng PY - 2026 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2026, v. 53, no. 1 TI - Assessing Alignment of Sexual Orientation and Sex of Sex Partners Among Men With Primary and Secondary Syphilis, 2022. VL - 53 UR - https://stacks.cdc.gov/view/cdc/261288 ER -
Decay Rate of Gas-phase Peracetic Acid in a Polyvinyl Fluoride Sample Bag.

Doepke, Amos ;

Streicher, Robert P.

August 2025 | Environmental Science. Processes & Impacts, 2025, v. 27, no. 8

In this study the temperature dependent decay rate of gas-phase peracetic acid (PAA) concentrations in polyvinyl fluoride (PVF) sample bags was measured. Headspace from a PAA solution was used to dynamically generate atmospheres of gas-phase PAA which were transferred to PVF bags. The concentration of gas-phase PAA in PVF bags, in a temperature-con ...

10/09/2026

Supporting Files

Title : Decay Rate of Gas-phase Peracetic Acid in a Polyvinyl Fluoride Sample Bag. Personal Author(s) : Doepke, Amos;Streicher, Robert P.;Stastny, Angela L.; Published Date : August 2025 Pages in Document : 2422-2431 (21 pdf pages) Source : Environmental Science. Processes & Impacts, 2025, v. 27, no. 8 DOI : https://doi.org/10.1039/d5em00286a Journal Title : Environmental Science. Processes & Impacts
Doepke, A., Streicher, R. P., & Stastny, A. L. (2025). Decay Rate of Gas-phase Peracetic Acid in a Polyvinyl Fluoride Sample Bag. Environmental Science. Processes & Impacts, 27(8). https://doi.org/10.1039/d5em00286a

Doepke, Amos, Robert P. Streicher, and Angela L. Stastny. "Decay Rate of Gas-phase Peracetic Acid in a Polyvinyl Fluoride Sample Bag." Environmental Science. Processes & Impacts 27, no. 8 (2025). https://doi.org/10.1039/d5em00286a.

Doepke, Amos, et al. "Decay Rate of Gas-phase Peracetic Acid in a Polyvinyl Fluoride Sample Bag." Environmental Science. Processes & Impacts, vol. 27, no. 8, 2025. Stacks. https://doi.org/10.1039/d5em00286a.
Export RIS Citation Information. TY - Journal Article AU - Doepke, Amos AU - Streicher, Robert P. AU - Stastny, Angela L. AB - In this study the temperature dependent decay rate of gas-phase peracetic acid (PAA) concentrations in polyvinyl fluoride (PVF) sample bags was measured. Headspace from a PAA solution was used to dynamically generate atmospheres of gas-phase PAA which were transferred to PVF bags. The concentration of gas-phase PAA in PVF bags, in a temperature-controlled environment, was measured AB - time using both selected ion flow-tube mass spectrometry (SIFT-MS) and impinger based colorimetric measurements. A review of PAA decomposition reactions, kinetics, and results of SIFT-MS measure of PAA and acetic acid are discussed. Gas-phase PAA concentrations in the PVF bags exhibited exponential decay consistent with first-order kinetics. The temperature dependent decay rate of gas-phase PAA concentration in PVF sample bags had half-lives that ranged from 19 h (at 30 °C) to 45 h (at 10 °C). From the Arrhenius equation, an activation energy of 34.2 ± 1.1 kJ mol AB - (8.2 ± 0.3 kcal mol AB - ) was calculated from the temperature dependence of the decay constant. In this work, the half-lives of gas-phase PAA concentrations measured in PVF were considerably longer than other studies of PAA in containers. AB - Author manuscript AN - cdc:261287 C4 - PMC12910449 DO - https://doi.org/10.1039/d5em00286a IS - 8 J2 - Environmental Science. Processes & Impacts KW - Polyvinyls KW - Temperature KW - Kinetics KW - Models, Chemical KW - Environmental Monitoring KW - Peracetic Acid KW - Air Pollutants KW - Gases KW - Polyvinyls KW - Peracetic Acid KW - Kinetics KW - Air Pollutants KW - Temperature KW - Environmental Monitoring KW - Gases KW - Models, Chemical LA - eng PY - 2025 T2 - Environmental Science. Processes & Impacts T2 - Environmental Science. Processes & Impacts, 2025, v. 27, no. 8 TI - Decay Rate of Gas-phase Peracetic Acid in a Polyvinyl Fluoride Sample Bag. VL - 27 UR - https://stacks.cdc.gov/view/cdc/261287 ER -
The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know.

Gold, Jeremy A. W. ;

Lipner, Shari R.

May 2025 | Cutis, 2025, v. 115, no. 5

The landscape of dermatophytosis is changing rapidly due to the global emergence of severe dermatophyte infections that frequently are resistant to first-line antifungal medications. We aimed to review the epidemiology of emerging dermatophyte infections and provide dermatologists with information needed for effective diagnosis and management. We e ...

10/09/2026

Supporting Files

Title : The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know. Personal Author(s) : Gold, Jeremy A. W.;Lipner, Shari R.; Published Date : May 2025 Pages in Document : 151-154 (9 pdf pages) Source : Cutis, 2025, v. 115, no. 5 DOI : https://doi.org/10.12788/cutis.1211 Journal Title : Cutis
Gold, J. A. W., & Lipner, S. R. (2025). The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know. Cutis, 115(5). https://doi.org/10.12788/cutis.1211

Gold, Jeremy A. W. and Shari R. Lipner. "The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know." Cutis 115, no. 5 (2025). https://doi.org/10.12788/cutis.1211.

Gold, Jeremy A. W., and Shari R. Lipner "The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know." Cutis, vol. 115, no. 5, 2025. Stacks. https://doi.org/10.12788/cutis.1211.
Export RIS Citation Information. TY - Journal Article AU - Gold, Jeremy A. W. AU - Lipner, Shari R. AB - The landscape of dermatophytosis is changing rapidly due to the global emergence of severe dermatophyte infections that frequently are resistant to first-line antifungal medications. We aimed to review the epidemiology of emerging dermatophyte infections and provide dermatologists with information needed for effective diagnosis and management. We emphasize the importance of proper diagnosis using mycological confirmation and judicious antifungal prescribing, and we review resources for obtaining laboratory testing to confirm the diagnosis of dermatophytosis caused by emerging species. AB - Author manuscript AN - cdc:261286 C4 - PMC12221198 DO - https://doi.org/10.12788/cutis.1211 IS - 5 J2 - Cutis KW - Dermatologists KW - Tinea KW - Drug Resistance, Fungal KW - Arthrodermataceae KW - Humans KW - Antifungal Agents KW - Dermatomycoses KW - Humans KW - Antifungal Agents KW - Drug Resistance, Fungal KW - Dermatomycoses KW - Tinea KW - Arthrodermataceae KW - Dermatologists LA - eng PY - 2025 T2 - Cutis T2 - Cutis, 2025, v. 115, no. 5 TI - The Rise of Antifungal-Resistant Dermatophyte Infections: What Dermatologists Need to Know. VL - 115 UR - https://stacks.cdc.gov/view/cdc/261286 ER -
Parental Reasons For Non-receipt of Influenza Vaccination Among Children 6 months-17 years and Changes Over Time, 2015-2024.

Kahn, Katherine E. ;

Santibanez, Tammy A.

August 2025 | Vaccine, 2025, v. 61

Understanding parental reasons for not having their child receive an influenza vaccination and how reasons have changed over time can help immunization programs and providers tailor interventions to increase uptake of influenza vaccine among children. The objectives of this study were to estimate the percentage of children 6 months-17 years with a ...

10/09/2026

Supporting Files

Title : Parental Reasons For Non-receipt of Influenza Vaccination Among Children 6 months-17 years and Changes Over Time, 2015-2024. Personal Author(s) : Kahn, Katherine E.;Santibanez, Tammy A.;Jain, Anurag;Zhou, Tianyi;Black, Carla L.; Published Date : August 2025 Pages in Document : 127415 (17 pdf pages) Source : Vaccine, 2025, v. 61 DOI : https://doi.org/10.1016/j.vaccine.2025.127415 Journal Title : Vaccine
Kahn, K. E., Santibanez, T. A., Jain, A., Zhou, T., & Black, C. L. (2025). Parental Reasons For Non-receipt of Influenza Vaccination Among Children 6 months-17 years and Changes Over Time, 2015-2024. Vaccine, 61. https://doi.org/10.1016/j.vaccine.2025.127415

Kahn, Katherine E., Tammy A. Santibanez, Anurag Jain, Tianyi Zhou, and Carla L. Black. "Parental Reasons For Non-receipt of Influenza Vaccination Among Children 6 months-17 years and Changes Over Time, 2015-2024." Vaccine 61 (2025). https://doi.org/10.1016/j.vaccine.2025.127415.

Kahn, Katherine E., et al. "Parental Reasons For Non-receipt of Influenza Vaccination Among Children 6 months-17 years and Changes Over Time, 2015-2024." Vaccine, vol. 61, 2025. Stacks. https://doi.org/10.1016/j.vaccine.2025.127415.
Export RIS Citation Information. TY - Journal Article AU - Kahn, Katherine E. AU - Santibanez, Tammy A. AU - Jain, Anurag AU - Zhou, Tianyi AU - Black, Carla L. AB - Understanding parental reasons for not having their child receive an influenza vaccination and how reasons have changed over time can help immunization programs and providers tailor interventions to increase uptake of influenza vaccine among children. The objectives of this study were to estimate the percentage of children 6 months-17 years with a parent who reported selected reasons for non-receipt of influenza vaccination (or "non-vaccination") during 2015-2024, assess whether there has been an increase or decrease in the reporting of each reason for non-vaccination, particularly pre versus post COVID-19 pandemic, and if reasons for non-vaccination differ by sociodemographic characteristics. AB - National Immunization Survey-Flu (NIS-Flu) parentally reported data for the 2015-16, 2016-17, 2019-20, 2022-23, and 2023-24 seasons were analyzed. Percentages of children not vaccinated against influenza whose parent reported each reason for non-vaccination, overall, by state, and by sociodemographic characteristics were calculated. Tests of association between sociodemographic characteristics and across seasons were conducted for each reason for non-vaccination using t-tests. AB - The most commonly reported reasons for non-receipt of influenza vaccination across all seasons studied were: belief their child is unlikely to get very sick from influenza, concern about side effects/safety, and belief influenza vaccines do not work very well (48.2 %, 43.3 %, and 37.0 %, respectively, in 2023-24). Parental reporting of thinking their child is unlikely to get very sick from influenza increased more than other reasons for non-vaccination since the COVID-19 pandemic. Across all seasons studied, very few reported access-related reasons. Reasons for non-vaccination varied by state and by demographic characteristics. AB - This study suggests that concern about influenza has decreased since the COVID-19 pandemic. A strong provider recommendation for influenza vaccination, including information about the safety of the vaccine and seriousness of influenza, could help increase influenza vaccination coverage among children. AB - Author manuscript AN - cdc:261285 C4 - PMC12908229 DO - https://doi.org/10.1016/j.vaccine.2025.127415 J2 - Vaccine KW - Adolescent KW - Female KW - Vaccination KW - Pandemics KW - Immunization Programs KW - Parents KW - SARS-CoV-2 KW - COVID-19 KW - Influenza Vaccines KW - Vaccination Hesitancy KW - Child KW - Surveys and Questionnaires KW - Infant KW - Male KW - Humans KW - Child, Preschool KW - Influenza, Human KW - Influenza KW - Vaccination KW - Hesitancy KW - Children KW - Humans KW - Influenza Vaccines KW - Parents KW - Adolescent KW - Influenza, Human KW - Child KW - Infant KW - Female KW - Child, Preschool KW - Male KW - COVID-19 KW - Vaccination KW - Surveys and Questionnaires KW - SARS-CoV-2 KW - Vaccination Hesitancy KW - Immunization Programs KW - Pandemics LA - eng PY - 2025 T2 - Vaccine T2 - Vaccine, 2025, v. 61 TI - Parental Reasons For Non-receipt of Influenza Vaccination Among Children 6 months-17 years and Changes Over Time, 2015-2024. VL - 61 UR - https://stacks.cdc.gov/view/cdc/261285 ER -
Hormone Therapy Use and Young-onset Breast Cancer: a Pooled Analysis of Prospective Cohorts Included in the Premenopausal Breast Cancer Collaborative Group.

O'Brien, Katie M. ;

House, Melissa G.

July 2025 | The Lancet. Oncology, 2025, v. 26, no. 7

Oestrogen plus progestin hormone therapy is an established risk factor for breast cancer in postmenopausal women. We examined the less well-studied association between exogenous hormones and breast cancer in young women, who might use hormone therapy after gynaecological surgery or to relieve perimenopausal symptoms.In this pooled cohort analysis, ...

10/09/2026

Supporting Files

Title : Hormone Therapy Use and Young-onset Breast Cancer: a Pooled Analysis of Prospective Cohorts Included in the Premenopausal Breast Cancer Collaborative Group. Personal Author(s) : O'Brien, Katie M.;House, Melissa G.;Goldberg, Mandy;Jones, Michael E.;Weinberg, Clarice R.;Berrington de Gonzalez, Amy;Bertrand, Kimberly A.;Blot, William J.;DeHart, Jessica Clague;Couch, Fergus J.;Garcia-Closas, Montserrat;Giles, Graham G.;Kirsh, Victoria A.;Kitahara, Cari M.;Koh, Woon-Puay;Park, Hannah Lui;Milne, Roger L.;Palmer, Julie R.;Patel, Alpa V.;Rohan, Thomas E.;Schoemaker, Minouk J.;Swerdlow, Anthony J.;Teras, Lauren R.;Vachon, Celine;Visvanathan, Kala;Yuan, Jian-Min;Zheng, Wei;Nichols, Hazel B.;Sandler, Dale P.; Published Date : July 2025 Pages in Document : 911-923 (26 pdf pages) Source : The Lancet. Oncology, 2025, v. 26, no. 7 DOI : https://doi.org/10.1016/S1470-2045(25)00211-6 Journal Title : The Lancet. Oncology
O'Brien, K. M., House, M. G., Goldberg, M., Jones, M. E., Weinberg, C. R., Berrington de Gonzalez, A., Bertrand, K. A., Blot, W. J., DeHart, J. C., Couch, F. J., Garcia-Closas, M., Giles, G. G., Kirsh, V. A., Kitahara, C. M., Koh, W. P., Park, H. L., Milne, R. L., Palmer, J. R., Patel, A. V., ... Sandler, D. P. (2025). Hormone Therapy Use and Young-onset Breast Cancer: a Pooled Analysis of Prospective Cohorts Included in the Premenopausal Breast Cancer Collaborative Group. The Lancet. Oncology, 26(7). https://doi.org/10.1016/S1470-2045(25)00211-6

O'Brien, Katie M., Melissa G. House, Mandy Goldberg, Michael E. Jones, Clarice R. Weinberg, Amy Berrington de Gonzalez, and Kimberly A. Bertrand, et al.. "Hormone Therapy Use and Young-onset Breast Cancer: a Pooled Analysis of Prospective Cohorts Included in the Premenopausal Breast Cancer Collaborative Group." The Lancet. Oncology 26, no. 7 (2025). https://doi.org/10.1016/S1470-2045(25)00211-6.

O'Brien, Katie M., et al. "Hormone Therapy Use and Young-onset Breast Cancer: a Pooled Analysis of Prospective Cohorts Included in the Premenopausal Breast Cancer Collaborative Group." The Lancet. Oncology, vol. 26, no. 7, 2025. Stacks. https://doi.org/10.1016/S1470-2045(25)00211-6.
Export RIS Citation Information. TY - Journal Article AU - O'Brien, Katie M. AU - House, Melissa G. AU - Goldberg, Mandy AU - Jones, Michael E. AU - Weinberg, Clarice R. AU - Berrington de Gonzalez, Amy AU - Bertrand, Kimberly A. AU - Blot, William J. AU - DeHart, Jessica Clague AU - Couch, Fergus J. AU - Garcia-Closas, Montserrat AU - Giles, Graham G. AU - Kirsh, Victoria A. AU - Kitahara, Cari M. AU - Koh, Woon-Puay AU - Park, Hannah Lui AU - Milne, Roger L. AU - Palmer, Julie R. AU - Patel, Alpa V. AU - Rohan, Thomas E. AU - Schoemaker, Minouk J. AU - Swerdlow, Anthony J. AU - Teras, Lauren R. AU - Vachon, Celine AU - Visvanathan, Kala AU - Yuan, Jian-Min AU - Zheng, Wei AU - Nichols, Hazel B. AU - Sandler, Dale P. AB - Oestrogen plus progestin hormone therapy is an established risk factor for breast cancer in postmenopausal women. We examined the less well-studied association between exogenous hormones and breast cancer in young women, who might use hormone therapy after gynaecological surgery or to relieve perimenopausal symptoms. AB - In this pooled cohort analysis, we investigated the relationship between exogenous hormones and breast cancer in young women using data from 10-13 prospective cohorts from North America, Europe, Asia, and Australia. The participating cohorts followed up women for incident breast cancer until age 55 years. We used cohort-stratified, multivariable-adjusted Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% CI for associations of hormone therapy with incident young-onset breast cancer. We also estimated risk differences based on cumulative risk until age 55 years. AB - We included 459 476 women aged 16-54 years (mean 42·0 years [IQR 35·5-49·2]), of whom 8455 (2%) developed young-onset breast cancer (diagnosed before age 55 years; median follow-up 7·8 years [5·2-11·2]). Overall, 15% of participants reported using hormone therapy, with oestrogen plus progestin hormone therapy (6%) and unopposed oestrogen (5%) being the most common types. Cumulative risk of young-onset breast cancer was 4·1% in non-users. Hormone therapy of any type was not associated with incident young-onset breast cancer (HR 0·96 [95% CI 0·88 to 1·04]), but ever oestrogen hormone therapy use was inversely associated (0·86 [0·75 to 0·98]; risk difference -0·5% [-1·0 to -0·0]). The HR for ever oestrogen plus progestin hormone therapy and young-onset breast cancer was 1·10 (0·98 to 1·24), with positive associations observed for long-term use (1·18 [1·01 to 1·38] for >2 years) and use among women without hysterectomy or bilateral oophorectomy (1·15 [1·02 to 1·31]). Oestrogen hormone therapy and young-onset breast cancer association was similar for all breast cancer subtypes, but oestrogen plus progestin hormone therapy was more strongly associated with oestrogen receptor negative (1·44 [1·11 to 1·88]) and triple-negative disease (1·50 [1·02 to 2·20]) than with other subtypes. AB - Oestrogen hormone therapy use was inversely associated with young-onset breast cancer, and oestrogen plus progestin hormone therapy was associated with higher young-onset breast cancer incidence among women with intact uterus and ovaries. These findings largely parallel results from studies of hormone use and later-onset breast cancer and provide novel evidence for establishing clinical recommendations among younger women. AB - NIH Intramural Research Program. AB - Author manuscript AN - cdc:261282 C4 - PMC12233149 DO - https://doi.org/10.1016/S1470-2045(25)00211-6 IS - 7 J2 - The Lancet. Oncology KW - Estrogen Replacement Therapy KW - Adolescent KW - Female KW - Progestins KW - Premenopause KW - Prospective Studies KW - Young Adult KW - Breast Neoplasms KW - Estrogens KW - Risk Factors KW - Incidence KW - Age of Onset KW - Middle Aged KW - Humans KW - Adult KW - young-onset breast cancer KW - hormone therapy KW - premenopausal breast cancer KW - pooled analysis KW - Humans KW - Female KW - Breast Neoplasms KW - Adult KW - Middle Aged KW - Prospective Studies KW - Adolescent KW - Young Adult KW - Premenopause KW - Age of Onset KW - Risk Factors KW - Progestins KW - Estrogen Replacement Therapy KW - Incidence KW - Estrogens LA - eng PY - 2025 T2 - The Lancet. Oncology T2 - The Lancet. Oncology, 2025, v. 26, no. 7 TI - Hormone Therapy Use and Young-onset Breast Cancer: a Pooled Analysis of Prospective Cohorts Included in the Premenopausal Breast Cancer Collaborative Group. VL - 26 UR - https://stacks.cdc.gov/view/cdc/261282 ER -
Recommendation on the Use of Viral Load Tests and Exclusion of CD4 Tests as Proxies For HIV Medical Visits.

Xia, Qiang ;

Irvine, Mary K.

September 2025 | Annals of Epidemiology, 2025, v. 109

Medical providers may order CD4 tests for people with HIV (PWH) without providing HIV care. We hypothesized that including CD4 tests as a proxy for HIV medical visits misclassifies PWH on linkage to, receipt of, and retention in care.We used 2021 HIV surveillance data from New York City for analysis and compared 2 proxies for HIV medical visits-one ...

10/09/2026

Supporting Files

Title : Recommendation on the Use of Viral Load Tests and Exclusion of CD4 Tests as Proxies For HIV Medical Visits. Personal Author(s) : Xia, Qiang;Irvine, Mary K.;Manandhar-Sasaki, Prima;Bertolino, Daniel;Abdelqader, Faisal;Peterson, Meghan;Nash, Denis;Torian, Lucia V.; Published Date : September 2025 Pages in Document : 46-51 (12 pdf pages) Source : Annals of Epidemiology, 2025, v. 109 DOI : https://doi.org/10.1016/j.annepidem.2025.06.017 Journal Title : Annals of Epidemiology
Xia, Q., Irvine, M. K., Manandhar-Sasaki, P., Bertolino, D., Abdelqader, F., Peterson, M., Nash, D., & Torian, L. V. (2025). Recommendation on the Use of Viral Load Tests and Exclusion of CD4 Tests as Proxies For HIV Medical Visits. Annals of Epidemiology, 109. https://doi.org/10.1016/j.annepidem.2025.06.017

Xia, Qiang, Mary K. Irvine, Prima Manandhar-Sasaki, Daniel Bertolino, Faisal Abdelqader, Meghan Peterson, Denis Nash, and Lucia V. Torian. "Recommendation on the Use of Viral Load Tests and Exclusion of CD4 Tests as Proxies For HIV Medical Visits." Annals of Epidemiology 109 (2025). https://doi.org/10.1016/j.annepidem.2025.06.017.

Xia, Qiang, et al. "Recommendation on the Use of Viral Load Tests and Exclusion of CD4 Tests as Proxies For HIV Medical Visits." Annals of Epidemiology, vol. 109, 2025. Stacks. https://doi.org/10.1016/j.annepidem.2025.06.017.
Export RIS Citation Information. TY - Journal Article AU - Xia, Qiang AU - Irvine, Mary K. AU - Manandhar-Sasaki, Prima AU - Bertolino, Daniel AU - Abdelqader, Faisal AU - Peterson, Meghan AU - Nash, Denis AU - Torian, Lucia V. AB - Medical providers may order CD4 tests for people with HIV (PWH) without providing HIV care. We hypothesized that including CD4 tests as a proxy for HIV medical visits misclassifies PWH on linkage to, receipt of, and retention in care. AB - We used 2021 HIV surveillance data from New York City for analysis and compared 2 proxies for HIV medical visits-one included the presence of either CD4 or viral load tests and the other included viral load tests-to measure linkage to care among people newly diagnosed with HIV and receipt of and retention in care among PWH. AB - In New York City in 2021, 1146 of 1399 people newly diagnosed with HIV (81.9 %) had timely linkage to care when either CD4 or viral load tests were used as proxies; 1118 of 1399 (79.9 %) people newly diagnosed with HIV had timely linkage to care when only viral load tests were used. A total of 69 982 of 76 338 PWH (91.7 %) were classified as having received HIV care in New York City in 2021 when either CD4 or viral load tests were used; 69 088 of 76 388 PWH (90.5 %) were classified as having received HIV care when only viral load tests were used. AB - Including CD4 tests as proxies for HIV medical visits misclassifies linkage to care among people newly diagnosed with HIV, and receipt of and retention in care among PWH. We recommend using viral load tests only as proxies to monitor progress toward goals of the National HIV/AIDS Strategy. AB - Author manuscript AN - cdc:261281 C4 - PMC12290990 DO - https://doi.org/10.1016/j.annepidem.2025.06.017 J2 - Annals of Epidemiology KW - CD4 Lymphocyte Count KW - Female KW - Male KW - Humans KW - Middle Aged KW - Adult KW - Retention in Care KW - HIV Infections KW - Viral Load KW - HIV KW - CD4 KW - viral load KW - surveillance KW - access to care KW - Humans KW - Viral Load KW - HIV Infections KW - CD4 Lymphocyte Count KW - Male KW - Female KW - Adult KW - Middle Aged KW - Retention in Care LA - eng PY - 2025 T2 - Annals of Epidemiology T2 - Annals of Epidemiology, 2025, v. 109 TI - Recommendation on the Use of Viral Load Tests and Exclusion of CD4 Tests as Proxies For HIV Medical Visits. VL - 109 UR - https://stacks.cdc.gov/view/cdc/261281 ER -
Surveying Holistic Well-Being For Work From Home Employees: Insights For Organizational Practices.

Li, Yifan ;

Francis-Levin, Jess

June 25, 2026 | IISE Transactions on Occupational Ergonomics and Human Factors, 2026, v. 13, no. 4

OCCUPATIONAL APPLICATIONSThe COVID-19 pandemic has significantly impacted workers and work. As Work from Home (WFH) modalities become more widely utilized, employers and workers alike face new benefits and challenges. The key aim of this report is to better understand the impact of WFH on the well-being of workers and identify potential risks of th ...

10/09/2026

Supporting Files

Title : Surveying Holistic Well-Being For Work From Home Employees: Insights For Organizational Practices. Personal Author(s) : Li, Yifan;Francis-Levin, Jess;German, Isabelle; Published Date : June 25, 2026 Pages in Document : 250-255 (9 pdf pages) Source : IISE Transactions on Occupational Ergonomics and Human Factors, 2026, v. 13, no. 4 DOI : https://doi.org/10.1080/24725838.2025.2524778 Journal Title : IISE Transactions on Occupational Ergonomics and Human Factors
Li, Y., Francis-Levin, J., & German, I. (2026). Surveying Holistic Well-Being For Work From Home Employees: Insights For Organizational Practices. IISE Transactions on Occupational Ergonomics and Human Factors, 13(4). https://doi.org/10.1080/24725838.2025.2524778

Li, Yifan, Jess Francis-Levin, and Isabelle German. "Surveying Holistic Well-Being For Work From Home Employees: Insights For Organizational Practices." IISE Transactions on Occupational Ergonomics and Human Factors 13, no. 4 (2026). https://doi.org/10.1080/24725838.2025.2524778.

Li, Yifan, et al. "Surveying Holistic Well-Being For Work From Home Employees: Insights For Organizational Practices." IISE Transactions on Occupational Ergonomics and Human Factors, vol. 13, no. 4, 2026. Stacks. https://doi.org/10.1080/24725838.2025.2524778.
Export RIS Citation Information. TY - Journal Article AU - Li, Yifan AU - Francis-Levin, Jess AU - German, Isabelle AB - OCCUPATIONAL APPLICATIONSThe COVID-19 pandemic has significantly impacted workers and work. As Work from Home (WFH) modalities become more widely utilized, employers and workers alike face new benefits and challenges. The key aim of this report is to better understand the impact of WFH on the well-being of workers and identify potential risks of the WFH environment for this population subset. Using the NIOSH Worker Well-Being Questionnaire (WellBQ) tool, we quantified worker's well-being across five categories defined by the tool. Scores from individual items within these categories were then evaluated across different demographic factors (age, gender, education level, income, and WFH level) to better understand the implications of the WFH modality for the diverse WFH workforce. Evaluating well-being against the demographic scores may shed light on groups that need additional support, resources and tools to perform their work and remain in good health. AB - Author manuscript AN - cdc:261280 C4 - PMC13296678 DO - https://doi.org/10.1080/24725838.2025.2524778 IS - 4 J2 - IISE Transactions on Occupational Ergonomics and Human Factors KW - Female KW - Holistic Health KW - SARS-CoV-2 KW - COVID-19 KW - Young Adult KW - Occupational Health KW - Workplace KW - Surveys and Questionnaires KW - Male KW - Middle Aged KW - Humans KW - Teleworking KW - Adult KW - Total worker health KW - WFH KW - remote work KW - NIOSH WellBQ KW - Humans KW - Male KW - COVID-19 KW - Female KW - Adult KW - Middle Aged KW - Surveys and Questionnaires KW - Occupational Health KW - SARS-CoV-2 KW - Teleworking KW - Holistic Health KW - Workplace KW - Young Adult LA - eng PY - 2026 T2 - IISE Transactions on Occupational Ergonomics and Human Factors T2 - IISE Transactions on Occupational Ergonomics and Human Factors, 2026, v. 13, no. 4 TI - Surveying Holistic Well-Being For Work From Home Employees: Insights For Organizational Practices. VL - 13 UR - https://stacks.cdc.gov/view/cdc/261280 ER -
Investigating the Quantitative Toxicological Relationship Between PFAS Alkyl Fluorine Structure and Exposure Levels Leading to Changes in Blood-based Clinical Markers in Rats.

Prussia, Andrew J. ;

Demchuk, Eugene

August 28, 2025 | Journal of Toxicology and Environmental Health. Part A, 2025, v. 88, no. 23

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are persistent organic pollutants, many of which exhibit lowclearance rates. The long-chain PFAS (≥6 perfluorinated carbons), due to low clearance rates, are often perceived to exert a higher toll on human health than short-chain PFAS. However, a comprehensive toxicological and epidemiological co ...

10/09/2026

Supporting Files

Title : Investigating the Quantitative Toxicological Relationship Between PFAS Alkyl Fluorine Structure and Exposure Levels Leading to Changes in Blood-based Clinical Markers in Rats. Personal Author(s) : Prussia, Andrew J.;Demchuk, Eugene; Published Date : August 28, 2025 Pages in Document : 981-996 (25 pdf pages) Source : Journal of Toxicology and Environmental Health. Part A, 2025, v. 88, no. 23 DOI : https://doi.org/10.1080/15287394.2025.2520427 Journal Title : Journal of Toxicology and Environmental Health. Part A
Prussia, A. J., & Demchuk, E. (2025). Investigating the Quantitative Toxicological Relationship Between PFAS Alkyl Fluorine Structure and Exposure Levels Leading to Changes in Blood-based Clinical Markers in Rats. Journal of Toxicology and Environmental Health. Part A, 88(23). https://doi.org/10.1080/15287394.2025.2520427

Prussia, Andrew J. and Eugene Demchuk. "Investigating the Quantitative Toxicological Relationship Between PFAS Alkyl Fluorine Structure and Exposure Levels Leading to Changes in Blood-based Clinical Markers in Rats." Journal of Toxicology and Environmental Health. Part A 88, no. 23 (2025). https://doi.org/10.1080/15287394.2025.2520427.

Prussia, Andrew J., and Eugene Demchuk "Investigating the Quantitative Toxicological Relationship Between PFAS Alkyl Fluorine Structure and Exposure Levels Leading to Changes in Blood-based Clinical Markers in Rats." Journal of Toxicology and Environmental Health. Part A, vol. 88, no. 23, 2025. Stacks. https://doi.org/10.1080/15287394.2025.2520427.
Export RIS Citation Information. TY - Journal Article AU - Prussia, Andrew J. AU - Demchuk, Eugene AB - Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are persistent organic pollutants, many of which exhibit low AB - clearance rates. The long-chain PFAS (≥6 perfluorinated carbons), due to low clearance rates, are often perceived to exert a higher toll on human health than short-chain PFAS. However, a comprehensive toxicological and epidemiological comparison of long- and short-chain PFAS is overdue, leaving significant data gaps and limitations. For the first time, this study investigated the quantitative relationship between overall PFAS fluorine structure (C-F bond), which includes the alkyl chain length as one component, and PFAS doses that trigger changes in rat blood-based clinical markers. Fifteen markers published by the National Toxicology Program (NTP) after 28-day exposure to 7 PFAS with both long- and short-chain perfluorinated alkyl structures were examined. The aim of this study was to (1) determine PFAS doses that trigger changes in the marker levels for hepatic, renal, cardiovascular, and metabolic systems and (2) use these doses in multiple linear regression models to examine relationship to variables describing PFAS chemical structures. Our findings showed a log-linear dependence of alterations in marker levels on PFAS fluorine structure, as measured in the number of alkyl carbon-fluorine (C-F) bonds. Each C-F bond affected the marker effect levels by 0.45 ± 0.01 mmol/kg-day. The variety of studied clinical markers suggests that PFAS exposures led to deviations in multiple biological pathways in the rat animal model, which may inform future research and regulatory decisions. AB - Author manuscript AN - cdc:261279 C4 - PMC12382308 DO - https://doi.org/10.1080/15287394.2025.2520427 IS - 23 J2 - Journal of Toxicology and Environmental Health. Part A KW - Biomarkers KW - Fluorocarbons KW - Environmental Pollutants KW - Animals KW - Fluorine KW - Rats, Sprague-Dawley KW - Male KW - Environmental Exposure KW - Rats KW - Perfluoroalkyl and polyfluoroalkyl substances (PFAS) KW - Perfluoroalkyl acids (PFAAs) KW - Fluorocarbons KW - Clinical markers KW - Dose-response analysis KW - Multiple linear regression models KW - Animals KW - Fluorocarbons KW - Rats KW - Biomarkers KW - Male KW - Environmental Pollutants KW - Rats, Sprague-Dawley KW - Fluorine KW - Environmental Exposure LA - eng PY - 2025 T2 - Journal of Toxicology and Environmental Health. Part A T2 - Journal of Toxicology and Environmental Health. Part A, 2025, v. 88, no. 23 TI - Investigating the Quantitative Toxicological Relationship Between PFAS Alkyl Fluorine Structure and Exposure Levels Leading to Changes in Blood-based Clinical Markers in Rats. VL - 88 UR - https://stacks.cdc.gov/view/cdc/261279 ER -
Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM.

Raiford, Jerris L ;

MacGowan, Robin J.

November 2025 | AIDS and Behavior, 2025, v. 29, no. 11

Gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV infection in the United States, especially Black MSM (BMSM) and Hispanic/Latino MSM (HLMSM). Long-acting preexposure prophylaxis (LA PrEP) is effective in preventing HIV; however, medical mistrust may contribute to barriers in uptake among BMSM and HLMSM ...

10/09/2026

Supporting Files

Title : Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM. Personal Author(s) : Raiford, Jerris L;MacGowan, Robin J.;Stephenson, Rob;Dana, Ruth;Hightow-Weidman, Lisa;Wall, Kristin M;Jones, Jeb;Sullivan, Patrick S.; Published Date : November 2025 Pages in Document : 3582-3594 (21 pdf pages) Source : AIDS and Behavior, 2025, v. 29, no. 11 DOI : https://doi.org/10.1007/s10461-025-04801-z Journal Title : AIDS and Behavior
Raiford, J. L., MacGowan, R. J., Stephenson, R., Dana, R., Hightow-Weidman, L., Wall, K. M., Jones, J., & Sullivan, P. S. (2025). Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM. AIDS and Behavior, 29(11). https://doi.org/10.1007/s10461-025-04801-z

Raiford, Jerris L, Robin J. MacGowan, Rob Stephenson, Ruth Dana, Lisa Hightow-Weidman, Kristin M Wall, Jeb Jones, and Patrick S. Sullivan. "Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM." AIDS and Behavior 29, no. 11 (2025). https://doi.org/10.1007/s10461-025-04801-z.

Raiford, Jerris L, et al. "Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM." AIDS and Behavior, vol. 29, no. 11, 2025. Stacks. https://doi.org/10.1007/s10461-025-04801-z.
Export RIS Citation Information. TY - Journal Article AU - Raiford, Jerris L AU - MacGowan, Robin J. AU - Stephenson, Rob AU - Dana, Ruth AU - Hightow-Weidman, Lisa AU - Wall, Kristin M AU - Jones, Jeb AU - Sullivan, Patrick S. AB - Gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV infection in the United States, especially Black MSM (BMSM) and Hispanic/Latino MSM (HLMSM). Long-acting preexposure prophylaxis (LA PrEP) is effective in preventing HIV; however, medical mistrust may contribute to barriers in uptake among BMSM and HLMSM. We assessed the role of medical mistrust in BMSM and HLMSM's unwillingness to use LA PrEP. BMSM and HLMSM aged ≥18 years without a previous HIV diagnosis or current PrEP use were recruited through dating and general interest websites/apps. Using Poisson regression with robust standard errors, we conducted multivariate analyses to assess the association between medical mistrust and willingness to use LA PrEP (i.e., injection or rod implanted in the arm) separately for each racial/ethnic group. Over 90% of the 1,126 BMSM and 924 HLMSM in this study were willing to use some form of PrEP; however, only 74% of BMSM and 81% of HLMSM were willing to use PrEP injections, and significantly fewer BMSM (30%) were willing to receive a PrEP implant compared with 44% of HLMSM. After controlling for sociodemographic, behavioral, and clinical covariates, medical mistrust was associated with lower willingness to use LA PrEP for BMSM, but not for HLMSM. Addressing and reducing medical mistrust among BMSM is important to increase the use of LA PrEP as an effective HIV prevention strategy. Addressing structural barriers and building trust within healthcare systems are crucial steps in reducing disparities in HIV infection among BMSM and HLMSM. AB - Author manuscript AN - cdc:261278 C4 - PMC12599396 DO - https://doi.org/10.1007/s10461-025-04801-z IS - 11 J2 - AIDS and Behavior KW - Professional Misconduct KW - History, 20th Century KW - Health Knowledge, Attitudes, Practice KW - Anti-HIV Agents KW - Trust KW - Hispanic or Latino KW - Young Adult KW - Malpractice KW - Homosexuality, Male KW - Sexual and Gender Minorities KW - Pre-Exposure Prophylaxis KW - Patient Acceptance of Health Care KW - Male KW - Humans KW - Middle Aged KW - Black or African American KW - Adult KW - Ethics, Medical KW - HIV Infections KW - MSM KW - Black KW - Hispanic/Latino KW - PrEP KW - long acting KW - willingness KW - medical mistrust KW - Adult KW - Humans KW - Male KW - Middle Aged KW - Young Adult KW - Anti-HIV Agents KW - Black or African American KW - Health Knowledge, Attitudes, Practice KW - Hispanic or Latino KW - HIV Infections KW - Homosexuality, Male KW - Patient Acceptance of Health Care KW - Pre-Exposure Prophylaxis KW - Sexual and Gender Minorities KW - Trust KW - Ethics, Medical KW - Professional Misconduct KW - History, 20th Century KW - Malpractice LA - eng PY - 2025 T2 - AIDS and Behavior T2 - AIDS and Behavior, 2025, v. 29, no. 11 TI - Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM. VL - 29 UR - https://stacks.cdc.gov/view/cdc/261278 ER -
Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States.

Gold, Jeremy A. W. ;

Benedict, Kaitlin

July 24, 2025 | Transplant Infectious Disease: An Official Journal of the Transplantation Society, 2025, v. 27, no. 5

Updated benchmark data on invasive fungal disease (IFD) in solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) recipients are necessary to increase clinical recognition and inform treatment and prevention strategies. We estimated IFD incidence and potential risk factors in transplant recipients in a large US commercial he ...

10/09/2026

Supporting Files

Title : Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States. Personal Author(s) : Gold, Jeremy A. W.;Benedict, Kaitlin;Sajewski, Elizabeth;Chiller, Tom;Lyman, Meghan;Toda, Mitsuru;Little, Jessica S.;Ostrosky-Zeichner, Luis; Published Date : July 24, 2025 Pages in Document : e70077 (18 pdf pages) Source : Transplant Infectious Disease: An Official Journal of the Transplantation Society, 2025, v. 27, no. 5 DOI : https://doi.org/10.1111/tid.70077 Journal Title : Transplant Infectious Disease: An Official Journal of the Transplantation Society
Gold, J. A. W., Benedict, K., Sajewski, E., Chiller, T., Lyman, M., Toda, M., Little, J. S., & Ostrosky-Zeichner, L. (2025). Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States. Transplant Infectious Disease: An Official Journal of the Transplantation Society, 27(5). https://doi.org/10.1111/tid.70077

Gold, Jeremy A. W., Kaitlin Benedict, Elizabeth Sajewski, Tom Chiller, Meghan Lyman, Mitsuru Toda, Jessica S. Little, and Luis Ostrosky-Zeichner. "Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States." Transplant Infectious Disease: An Official Journal of the Transplantation Society 27, no. 5 (2025). https://doi.org/10.1111/tid.70077.

Gold, Jeremy A. W., et al. "Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States." Transplant Infectious Disease: An Official Journal of the Transplantation Society, vol. 27, no. 5, 2025. Stacks. https://doi.org/10.1111/tid.70077.
Export RIS Citation Information. TY - Journal Article AU - Gold, Jeremy A. W. AU - Benedict, Kaitlin AU - Sajewski, Elizabeth AU - Chiller, Tom AU - Lyman, Meghan AU - Toda, Mitsuru AU - Little, Jessica S. AU - Ostrosky-Zeichner, Luis AB - Updated benchmark data on invasive fungal disease (IFD) in solid organ transplantation (SOT) and hematopoietic cell transplantation (HCT) recipients are necessary to increase clinical recognition and inform treatment and prevention strategies. We estimated IFD incidence and potential risk factors in transplant recipients in a large US commercial health insurance database. AB - We observed patients who received SOT or HCT during 2018-2022 until IFD development, disenrollment, or database end date (July 31, 2023). We calculated incidence (per 1000 person-years) and time to IFD development, comparing demographic features and underlying conditions for IFD versus non-IFD patients. AB - Overall, 9143 patients received an SOT (5667 kidney, 2025 liver, 759 heart, 650 lung, 39 pancreas, 3 intestine), and 5693 patients received an HCT (3519 autologous, 2114 allogeneic, 60 unspecified type). Among SOT patients, 360 developed an IFD (incidence: 21.0 [per 1000 person-years]). Mold infections had the highest incidence (7.1), followed by unspecified mycoses (3.9) and endemic mycoses (3.3). Among HCT patients, 292 developed an IFD (incidence: 28.5), with higher incidence among allogeneic (58.4) versus autologous (12.8) HCT recipients; among all HCT recipients, unspecified mycoses had the highest incidence (8.3), then pneumocystosis (7.6), and mold infections (6.7). Median time to IFD was 173.5 days for SOT recipients and 197.5 days for HCT recipients. IFD risk varied substantially by transplant type, region, and certain underlying conditions. AB - Our results suggest that IFDs remain an important cause of infection among SOT and HCT recipients, particularly later in the posttransplant period, and highlight the need for prevention strategies. AB - Author manuscript AN - cdc:261277 C4 - PMC12289323 DO - https://doi.org/10.1111/tid.70077 IS - 5 J2 - Transplant Infectious Disease: An Official Journal of the Transplantation Society KW - Adolescent KW - Organ Transplantation KW - Female KW - Aged KW - Infant, Newborn KW - Young Adult KW - Invasive Fungal Infections KW - Child KW - Databases, Factual KW - Risk Factors KW - Infant KW - Male KW - Humans KW - Hematopoietic Stem Cell Transplantation KW - Middle Aged KW - Child, Preschool KW - Adult KW - aspergillosis KW - candidiasis KW - cryptococcosis KW - invasive fungal disease KW - pneumocystosis KW - solid organ transplantation KW - stem cell transplantation KW - Hematopoietic Stem Cell Transplantation KW - Humans KW - Male KW - Female KW - Adult KW - Middle Aged KW - Invasive Fungal Infections KW - Organ Transplantation KW - Databases, Factual KW - Risk Factors KW - Infant, Newborn KW - Infant KW - Child, Preschool KW - Child KW - Adolescent KW - Young Adult KW - Aged LA - eng PY - 2025 T2 - Transplant Infectious Disease: An Official Journal of the Transplantation Society T2 - Transplant Infectious Disease: An Official Journal of the Transplantation Society, 2025, v. 27, no. 5 TI - Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States. VL - 27 UR - https://stacks.cdc.gov/view/cdc/261277 ER -
Expansion of tetM-Carrying Neisseria gonorrhoeae in the US, 2018-2024

Helekal, David ;

Mortimer, Tatum D.

July 10, 2025 | The New England Journal of Medicine, 2025, v. 393, no. 2

Doxycycline use for bacterial sexually transmitted infections (STIs) increased in recent years due to changes in treatment guidelines, the shortage of benzathine penicillin for treatment of syphilis, and adoption of doxycycline post-exposure prophylaxis (doxy-PEP). While this increased use is expected to select for doxycycline resistance, particula ...

10/09/2026

Supporting Files

Title : Expansion of tetM-Carrying Neisseria gonorrhoeae in the US, 2018-2024 Personal Author(s) : Helekal, David;Mortimer, Tatum D.;Grad, Yonatan H.; Published Date : July 10, 2025 Pages in Document : 198-200 (3 pdf pages) Source : The New England Journal of Medicine, 2025, v. 393, no. 2 DOI : https://doi.org/10.1056/NEJMc2504010 Journal Title : The New England Journal of Medicine
Helekal, D., Mortimer, T. D., & Grad, Y. H. (2025). Expansion of tetM-Carrying Neisseria gonorrhoeae in the US, 2018-2024. The New England Journal of Medicine, 393(2). https://doi.org/10.1056/NEJMc2504010

Helekal, David, Tatum D. Mortimer, and Yonatan H. Grad. "Expansion of tetM-Carrying Neisseria gonorrhoeae in the US, 2018-2024." The New England Journal of Medicine 393, no. 2 (2025). https://doi.org/10.1056/NEJMc2504010.

Helekal, David, et al. "Expansion of tetM-Carrying Neisseria gonorrhoeae in the US, 2018-2024." The New England Journal of Medicine, vol. 393, no. 2, 2025. Stacks. https://doi.org/10.1056/NEJMc2504010.
Export RIS Citation Information. TY - Journal Article AU - Helekal, David AU - Mortimer, Tatum D. AU - Grad, Yonatan H. AB - Doxycycline use for bacterial sexually transmitted infections (STIs) increased in recent years due to changes in treatment guidelines, the shortage of benzathine penicillin for treatment of syphilis, and adoption of doxycycline post-exposure prophylaxis (doxy-PEP). While this increased use is expected to select for doxycycline resistance, particularly in Neisseria gonorrhoeae, the impact has been unclear. Here, we analyzed over 14,000 publicly available N. gonorrhoeae genome sequences from 2018-2024 generated through the US Centers for Disease Control and Prevention N. gonorrhoeae surveillance system, assessed the distribution of tetM, a plasmid-borne gene conferring high-level (MIC ≥ 16μg/mL) tetracycline resistance, and evaluated the spatial, temporal, and evolutionary dynamics of its spread AB - Author manuscript AN - cdc:261276 C4 - PMC12243957 DO - https://doi.org/10.1056/NEJMc2504010 IS - 2 J2 - The New England Journal of Medicine KW - Syphilis KW - Neisseria gonorrhoeae KW - Plasmids KW - Penicillin G Benzathine KW - Post-Exposure Prophylaxis KW - Doxycycline KW - Tetracycline Resistance KW - Doxycycline KW - Neisseria gonorrhoeae KW - Penicillin G Benzathine KW - Post-Exposure Prophylaxis KW - Syphilis KW - Tetracycline Resistance KW - Plasmids LA - eng PY - 2025 T2 - The New England Journal of Medicine T2 - The New England Journal of Medicine, 2025, v. 393, no. 2 TI - Expansion of tetM-Carrying Neisseria gonorrhoeae in the US, 2018-2024 VL - 393 UR - https://stacks.cdc.gov/view/cdc/261276 ER -
Safety of Hormonal Contraception Among Women With Liver Disease: an Updated Systematic Review.

Kapp, Nathalie ;

Tepper, Naomi K.

July 2026 | qq11, 2026, v. 159

We sought to assess whether, among women with liver disease, there is an increased risk of adverse health effects with the use of hormonal contraception (HC).We conducted a systematic review of six databases from database inception through December 13, 2022. We searched for articles that examined changes in liver lesions and acute and chronic liver ...

10/09/2026

Supporting Files

Title : Safety of Hormonal Contraception Among Women With Liver Disease: an Updated Systematic Review. Personal Author(s) : Kapp, Nathalie;Tepper, Naomi K.;Nguyen, Antoinette T.;Garbarino, Sophia;Kortsmit, Katherine;Curtis, Kathryn M.;Whiteman, Maura K.; Published Date : July 2026 Pages in Document : 111012 (17 pdf pages) Source : qq11, 2026, v. 159 DOI : https://doi.org/10.1016/j.contraception.2025.111012 Journal Title : qq11
Kapp, N., Tepper, N. K., Nguyen, A. T., Garbarino, S., Kortsmit, K., Curtis, K. M., & Whiteman, M. K. (2026). Safety of Hormonal Contraception Among Women With Liver Disease: an Updated Systematic Review. qq11, 159. https://doi.org/10.1016/j.contraception.2025.111012

Kapp, Nathalie, Naomi K. Tepper, Antoinette T. Nguyen, Sophia Garbarino, Katherine Kortsmit, Kathryn M. Curtis, and Maura K. Whiteman. "Safety of Hormonal Contraception Among Women With Liver Disease: an Updated Systematic Review." qq11 159 (2026). https://doi.org/10.1016/j.contraception.2025.111012.

Kapp, Nathalie, et al. "Safety of Hormonal Contraception Among Women With Liver Disease: an Updated Systematic Review." qq11, vol. 159, 2026. Stacks. https://doi.org/10.1016/j.contraception.2025.111012.
Export RIS Citation Information. TY - Journal Article AU - Kapp, Nathalie AU - Tepper, Naomi K. AU - Nguyen, Antoinette T. AU - Garbarino, Sophia AU - Kortsmit, Katherine AU - Curtis, Kathryn M. AU - Whiteman, Maura K. AB - We sought to assess whether, among women with liver disease, there is an increased risk of adverse health effects with the use of hormonal contraception (HC). AB - We conducted a systematic review of six databases from database inception through December 13, 2022. We searched for articles that examined changes in liver lesions and acute and chronic liver disease with the use of HC or after discontinuation of HC. We assessed the risk of bias for each study and certainty of evidence for all outcomes. AB - Thirteen articles met inclusion criteria, one with low risk of bias and the others with high risk of bias: three studies (four articles) were of women with focal nodular hyperplasia (FNH), five studies were of hepatocellular adenoma (HCA), and four studies were of acute or chronic hepatitis. The size and/or number of FNH lesions were generally not influenced by HC use. HCA progression was generally higher among current combined oral contraception (COC) users than those who discontinued, and lesions were stable or regressed in most women who discontinued COC or used progestin-only contraception. Studies found that viral hepatitis generally did not progress or increase in severity with the use of COC. AB - Overall, a limited body of evidence suggested changes in FNH lesions were independent of hormonal contraceptive use. Estrogen-containing contraceptive method use was associated with HCA lesion progression; lesions generally remained stable with progestin-only contraceptive use. COC use did not increase progression or severity of disease among those with viral hepatitis. The certainty of evidence for all outcomes was very low. AB - Liver conditions such as liver lesions, viral hepatitis, and cirrhosis are increasingly common in women of reproductive age. Information in this review can be used by health care providers when counseling women with liver disease about the safe use of contraception. AB - Author manuscript AN - cdc:261275 C4 - PMC12369956 DO - https://doi.org/10.1016/j.contraception.2025.111012 J2 - qq11 KW - Hepatitis KW - Systematic Review KW - Hormonal Contraception KW - Focal Nodular Hyperplasia KW - Contraceptives, Oral, Combined KW - Liver Diseases KW - Adenoma, Liver Cell KW - Combined oral contraception KW - Focal nodular hyperplasia KW - Hepatitis KW - Hepatocellular adenoma KW - Hormonal contraception KW - Liver disease KW - Systematic review KW - Contraceptives, Oral, Combined KW - Focal Nodular Hyperplasia KW - Hepatitis KW - Adenoma, Liver Cell KW - Hormonal Contraception KW - Liver Diseases KW - Systematic Review LA - eng PY - 2026 T2 - qq11 T2 - qq11, 2026, v. 159 TI - Safety of Hormonal Contraception Among Women With Liver Disease: an Updated Systematic Review. VL - 159 UR - https://stacks.cdc.gov/view/cdc/261275 ER -
Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022.

Spencer, Hunter C. ;

Town, Matthew A.

December 2025 | AIDS and Behavior, 2025, v. 29, no. 12

HIV pre-exposure prophylaxis (PrEP) prevents HIV transmission. However, PrEP remains underutilized among people who inject drugs (PWID), even when clinically indicated. Here, we assess changes in PrEP awareness, access, and use in 2018 and 2022 and factors associated with PrEP awareness in 2022. We analyzed a sample of PWID not living with HIV with ...

10/09/2026

Supporting Files

Title : Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022. Personal Author(s) : Spencer, Hunter C.;Town, Matthew A.;Sevillano, LaLaine;Lipira, Lauren;Menza, Tim W.; Published Date : December 2025 Pages in Document : 3822-3829 (16 pdf pages) Source : AIDS and Behavior, 2025, v. 29, no. 12 DOI : https://doi.org/10.1007/s10461-025-04819-3 Journal Title : AIDS and Behavior
Spencer, H. C., Town, M. A., Sevillano, L., Lipira, L., & Menza, T. W. (2025). Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022. AIDS and Behavior, 29(12). https://doi.org/10.1007/s10461-025-04819-3

Spencer, Hunter C., Matthew A. Town, LaLaine Sevillano, Lauren Lipira, and Tim W. Menza. "Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022." AIDS and Behavior 29, no. 12 (2025). https://doi.org/10.1007/s10461-025-04819-3.

Spencer, Hunter C., et al. "Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022." AIDS and Behavior, vol. 29, no. 12, 2025. Stacks. https://doi.org/10.1007/s10461-025-04819-3.
Export RIS Citation Information. TY - Journal Article AU - Spencer, Hunter C. AU - Town, Matthew A. AU - Sevillano, LaLaine AU - Lipira, Lauren AU - Menza, Tim W. AB - HIV pre-exposure prophylaxis (PrEP) prevents HIV transmission. However, PrEP remains underutilized among people who inject drugs (PWID), even when clinically indicated. Here, we assess changes in PrEP awareness, access, and use in 2018 and 2022 and factors associated with PrEP awareness in 2022. We analyzed a sample of PWID not living with HIV with an indication for PrEP based on National HIV Behavioral Surveillance (NHBS) in Portland, Oregon during the 2018 and 2022 survey cycles. We compared PrEP awareness, access, and use in 2018 and 2022 with χ AB - . Using 2018 and 2022 data, we compared PrEP awareness between the two years with a Poisson regression. Using 2022 data, we assessed factors associated with PrEP awareness. Compared to 2018, PrEP awareness was higher in 2022 (33% vs 17%, p < 0.001, aPR = 1.24, 95% CI = 1.14-1.36). There were no significant differences in PrEP access or use between 2018 to 2022. In the 2022 sample, PrEP awareness was higher among those with Hispanic ethnicity compared to white, non-Hispanic PWID (aPR = 2.18, 95% CI = 1.21-3.90) and previous drug treatment (aPR = 1.79, 95% CI = 1.20-2.69). Although PrEP awareness was higher in 2022 than 2018, PrEP access and use were unchanged and remained rare. PrEP use among PWID remains insufficient to meet national Ending the HIV Epidemic goals. AB - Author manuscript AN - cdc:261274 C4 - PMC12676974 DO - https://doi.org/10.1007/s10461-025-04819-3 IS - 12 J2 - AIDS and Behavior KW - Female KW - Health Knowledge, Attitudes, Practice KW - Anti-HIV Agents KW - Young Adult KW - Pre-Exposure Prophylaxis KW - Surveys and Questionnaires KW - Drug Users KW - Male KW - Humans KW - Middle Aged KW - Health Services Accessibility KW - Substance Abuse, Intravenous KW - Adult KW - HIV Infections KW - HIV KW - HIV Prevention KW - Pre-exposure prophylaxis (PrEP) KW - PrEP awareness KW - people who inject drugs (PWID) KW - Humans KW - HIV Infections KW - Substance Abuse, Intravenous KW - Pre-Exposure Prophylaxis KW - Male KW - Female KW - Adult KW - Middle Aged KW - Health Knowledge, Attitudes, Practice KW - Anti-HIV Agents KW - Health Services Accessibility KW - Drug Users KW - Young Adult KW - Surveys and Questionnaires LA - eng PY - 2025 T2 - AIDS and Behavior T2 - AIDS and Behavior, 2025, v. 29, no. 12 TI - Changes in the PrEP Care Cascade in People Who Inject Drugs in 2018 and 2022. VL - 29 UR - https://stacks.cdc.gov/view/cdc/261274 ER -
Assessment of School-Related Covid-19 Concerns Among Parents of School-Aged Children - United States, January 2021.

Young, Emily ;

Strine, Tara

July 9, 2025 | Planning & Changing, 2025, v. 51, no. 34

COVID-19-related disruptions to K-12 schooling were documented throughout the pandemic, along with parental concerns about the impact of COVID-19 on children's education. This study describes school-related COVID-19 concerns among parents of school-aged children across the United States in January 2021. Cross-sectional data (n=916) were analyzed fr ...

10/09/2026

Supporting Files

Title : Assessment of School-Related Covid-19 Concerns Among Parents of School-Aged Children - United States, January 2021. Personal Author(s) : Young, Emily;Strine, Tara;Szucs, Leigh;Swanson, Megan;Lane, Rashon;Bamkole, Omoshalewa;Sliwa, Sarah;Mark-Carew, Miguella;Verlenden, Jorge V.; Published Date : July 9, 2025 Pages in Document : 142-158 (13 pdf pages) Source : Planning & Changing, 2025, v. 51, no. 34 DOI : https://doi.org/10.1377/hlthaff.2020.00598 Journal Title : Planning & Changing
Young, E., Strine, T., Szucs, L., Swanson, M., Lane, R., Bamkole, O., Sliwa, S., Mark-Carew, M., & Verlenden, J. V. (2025). Assessment of School-Related Covid-19 Concerns Among Parents of School-Aged Children - United States, January 2021. Planning & Changing, 51(34). https://doi.org/10.1377/hlthaff.2020.00598

Young, Emily, Tara Strine, Leigh Szucs, Megan Swanson, Rashon Lane, Omoshalewa Bamkole, Sarah Sliwa, Miguella Mark-Carew, and Jorge V. Verlenden. "Assessment of School-Related Covid-19 Concerns Among Parents of School-Aged Children - United States, January 2021." Planning & Changing 51, no. 34 (2025). https://doi.org/10.1377/hlthaff.2020.00598.

Young, Emily, et al. "Assessment of School-Related Covid-19 Concerns Among Parents of School-Aged Children - United States, January 2021." Planning & Changing, vol. 51, no. 34, 2025. Stacks. https://doi.org/10.1377/hlthaff.2020.00598.
Export RIS Citation Information. TY - Journal Article AU - Young, Emily AU - Strine, Tara AU - Szucs, Leigh AU - Swanson, Megan AU - Lane, Rashon AU - Bamkole, Omoshalewa AU - Sliwa, Sarah AU - Mark-Carew, Miguella AU - Verlenden, Jorge V. AB - COVID-19-related disruptions to K-12 schooling were documented throughout the pandemic, along with parental concerns about the impact of COVID-19 on children's education. This study describes school-related COVID-19 concerns among parents of school-aged children across the United States in January 2021. Cross-sectional data (n=916) were analyzed from parents of children enrolled in public or private K-12 schools through an opt-in internet panel survey. Weighted prevalence estimates were calculated based on the U.S. Census Current Population Survey and differences were examined by race/ethnicity. Analyses were performed using SAS, version 9.4, with a significance level of p<0.05. Almost half of parents (46.4%) reported their children received virtual-only learning, 24.0% in-person only learning, and 29.6% combined in-person/virtual learning during fall 2020. School learning mode differed by parental race/ethnicity (p = 0.01). Parents reported concerns (somewhat/very concerned) about educational quality (85.2%) and disruption to routines due to virtual learning (70.8%), as well as children contracting COVID-19 at school (82.9%). Parent concerns about children contracting COVID-19 at school differed across racial and ethnic groups (p = 0.03), with a higher proportion of non-Hispanic Black parents (94.0%; p = 0.003) reporting concerns than non-Hispanic white parents (80.2%). Results document racial and ethnic differences in parental concern about the pandemic's impact on children's school experiences. Intentional monitoring and understanding of parental concerns may help education and public health leaders provide more effective supports for students and families as new school-related emergencies arise. AB - Author manuscript AN - cdc:261273 C4 - PMC12238931 DO - https://doi.org/10.1377/hlthaff.2020.00598 IS - 34 J2 - Planning & Changing KW - Emergencies KW - Cross-Sectional Studies KW - Ethnicity KW - Internet KW - Pandemics KW - Students KW - Prevalence KW - Parents KW - Public Health KW - Censuses KW - COVID-19 KW - Education, Distance KW - Schools KW - parental concerns KW - COVID-19 KW - racial and ethnic differences KW - educational leadership KW - emergency preparedness and communication KW - COVID-19 KW - Censuses KW - Cross-Sectional Studies KW - Education, Distance KW - Emergencies KW - Ethnicity KW - Pandemics KW - Prevalence KW - Public Health KW - Internet KW - Parents KW - Students LA - eng PY - 2025 T2 - Planning & Changing T2 - Planning & Changing, 2025, v. 51, no. 34 TI - Assessment of School-Related Covid-19 Concerns Among Parents of School-Aged Children - United States, January 2021. VL - 51 UR - https://stacks.cdc.gov/view/cdc/261273 ER -
Incentivized Community-Based Syphilis Screening: Uptake, Yield, and Cost.

O'Connell, Meghan Curry ;

Duran, Tinka

December 2025 | Sexually Transmitted Diseases, 2025, v. 52, no. 12

High and increasing syphilis rates among American Indian/Alaska Native communities and particularly among American Indian/Alaska Native women and infants call for immediate interventions to reach and offer syphilis testing to sexually active populations paired with timely treatment.The Great Plains Tribal Epidemiology Center within the Great Plains ...

10/09/2026

Supporting Files

Title : Incentivized Community-Based Syphilis Screening: Uptake, Yield, and Cost. Personal Author(s) : O'Connell, Meghan Curry;Duran, Tinka;Shewbrooks, Sarah;Wang, Cheng;Broghammer, Tyler;Weasel, Emily Good;Taylor, Melanie M.;Means, Tipi; Published Date : December 2025 Pages in Document : 775-779 (12 pdf pages) Source : Sexually Transmitted Diseases, 2025, v. 52, no. 12 DOI : https://doi.org/10.1097/OLQ.0000000000002219 Journal Title : Sexually Transmitted Diseases
O'Connell, M. C., Duran, T., Shewbrooks, S., Wang, C., Broghammer, T., Weasel, E. G., Taylor, M. M., & Means, T. (2025). Incentivized Community-Based Syphilis Screening: Uptake, Yield, and Cost. Sexually Transmitted Diseases, 52(12). https://doi.org/10.1097/OLQ.0000000000002219

O'Connell, Meghan Curry, Tinka Duran, Sarah Shewbrooks, Cheng Wang, Tyler Broghammer, Emily Good Weasel, Melanie M. Taylor, and Tipi Means. "Incentivized Community-Based Syphilis Screening: Uptake, Yield, and Cost." Sexually Transmitted Diseases 52, no. 12 (2025). https://doi.org/10.1097/OLQ.0000000000002219.

O'Connell, Meghan Curry, et al. "Incentivized Community-Based Syphilis Screening: Uptake, Yield, and Cost." Sexually Transmitted Diseases, vol. 52, no. 12, 2025. Stacks. https://doi.org/10.1097/OLQ.0000000000002219.
Export RIS Citation Information. TY - Journal Article AU - O'Connell, Meghan Curry AU - Duran, Tinka AU - Shewbrooks, Sarah AU - Wang, Cheng AU - Broghammer, Tyler AU - Weasel, Emily Good AU - Taylor, Melanie M. AU - Means, Tipi AB - High and increasing syphilis rates among American Indian/Alaska Native communities and particularly among American Indian/Alaska Native women and infants call for immediate interventions to reach and offer syphilis testing to sexually active populations paired with timely treatment. AB - The Great Plains Tribal Epidemiology Center within the Great Plains Tribal Leaders Health Board partnered with a local nontribal health care facility to offer free community-based syphilis testing in Rapid City, South Dakota, starting in December 2022 through June 2024. Participants received cash incentive cards for undergoing testing for syphilis, human immunodeficiency virus (HIV), and hepatitis C virus. AB - Fifteen community testing events were conducted. Laboratory-based syphilis testing was performed on 1434 unique individuals with an average age of 38.8 years. Seventy-six people were diagnosed with syphilis that had previously not been identified (prevalence, 5.3% [76 of 1434]; 51 [67.1%]) were female. Treatment was provided to 80.3% of people with syphilis (61 of 76) within an average of 36 days. In total, the 15 events cost $158,019 ($75,000 administrative staff time + $5100 laboratory staff time + $24,009 laboratory tests + $ 53,910 incentives) or $88 per test performed ($158,019 per 1797). The cost to identify a previously unidentified case was $2079 ($158,019 per 76 newly identified infected persons). AB - This community-based screening event revealed high prevalence of undiagnosed syphilis. Incentives supported community members to access screening services. Collaborations between clinical, tribal, and public health entities to bring diagnosis and treatment services to patients using a community-based approach have clear benefits but need ongoing supportive resources to be maintained. AB - Author manuscript AN - cdc:261272 C4 - PMC12377399 DO - https://doi.org/10.1097/OLQ.0000000000002219 IS - 12 J2 - Sexually Transmitted Diseases KW - Adolescent KW - Female KW - Mass Screening KW - Young Adult KW - Syphilis KW - Prevalence KW - Motivation KW - Male KW - Humans KW - Middle Aged KW - Indians, North American KW - Community Health Services KW - Adult KW - HIV Infections KW - syphilis KW - community-based screening KW - American Indian/Alaska Native KW - Adolescent KW - Adult KW - Female KW - Humans KW - Male KW - Middle Aged KW - Young Adult KW - Community Health Services KW - HIV Infections KW - Indians, North American KW - Mass Screening KW - Motivation KW - Prevalence KW - Syphilis LA - eng PY - 2025 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2025, v. 52, no. 12 TI - Incentivized Community-Based Syphilis Screening: Uptake, Yield, and Cost. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261272 ER -
Healthcare Expenditure on Older Adult Non-fatal Falls by State.

Miller, Gabrielle F ;

Haddad, Yara K

July 2025 | Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, July 2025

Falls are a leading preventable cause of death and injury among older adults (65+). Healthcare spending in the USA on non-fatal falls was estimated at $80 billion in 2020. We aim to estimate healthcare spending on older adult non-fatal falls by state.Healthcare spending for all adults was derived from the 2020 Centers for Medicare and Medicaid Serv ...

10/09/2026

Supporting Files

Title : Healthcare Expenditure on Older Adult Non-fatal Falls by State. Personal Author(s) : Miller, Gabrielle F;Haddad, Yara K;Ortmann, Neil;Florence, Curtis; Published Date : July 2025 Pages in Document : ip-2025 (13 pdf pages) Source : Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, July 2025 DOI : https://doi.org/10.1136/ip-2025-045725 Journal Title : Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
Miller, G. F., Haddad, Y. K., Ortmann, N., & Florence, C. (2025). Healthcare Expenditure on Older Adult Non-fatal Falls by State. Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention. https://doi.org/10.1136/ip-2025-045725

Miller, Gabrielle F, Yara K Haddad, Neil Ortmann, and Curtis Florence. "Healthcare Expenditure on Older Adult Non-fatal Falls by State." Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention (2025). https://doi.org/10.1136/ip-2025-045725.

Miller, Gabrielle F, et al. "Healthcare Expenditure on Older Adult Non-fatal Falls by State." Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2025. Stacks. https://doi.org/10.1136/ip-2025-045725.
Export RIS Citation Information. TY - Journal Article AU - Miller, Gabrielle F AU - Haddad, Yara K AU - Ortmann, Neil AU - Florence, Curtis AB - Falls are a leading preventable cause of death and injury among older adults (65+). Healthcare spending in the USA on non-fatal falls was estimated at $80 billion in 2020. We aim to estimate healthcare spending on older adult non-fatal falls by state. AB - Healthcare spending for all adults was derived from the 2020 Centers for Medicare and Medicaid Services (CMS) Health Expenditures by State of Residence files. These data covered three payor types: Medicare, Medicaid and private health insurance (PHI). Using the national 2020 CMS Health Expenditure by Age Group files, the national proportion of healthcare spending for older adults was calculated for each payor type. These national proportions were applied to each state's healthcare spending data to estimate healthcare spending for older adults in each state, adjusted for the proportion of older adults in each state. To estimate the proportion of older adult healthcare spending attributed to non-fatal falls, these adjusted values were combined with the falls-attributable expenditure factors calculated in Haddad (2024). The final state-level estimates of healthcare spending on non-fatal older adult falls were calculated for each payer type: Medicare, Medicaid and PHI. All estimates were inflated to 2023 dollars. AB - Overall state-level spending on non-fatal falls ranged between $112.7 million in Alaska to $8.3 billion in Florida. Per-capita spending estimates ranged between $1085 in Utah to $2262 in Wisconsin. AB - Measuring the cost of non-fatal falls at the state level can help inform regional differences and improve targeted fall prevention efforts. AB - Author manuscript AN - cdc:261271 C4 - PMC13044968 DO - https://doi.org/10.1136/ip-2025-045725 J2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention LA - eng PY - 2025 T2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention T2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, July 2025 TI - Healthcare Expenditure on Older Adult Non-fatal Falls by State. UR - https://stacks.cdc.gov/view/cdc/261271 ER -
Maternal Occupational Exposure to Noise: Prevalence, Maternal Effects and Infant Outcomes in the National Birth Defects Prevention Study, 1997-2011.

Van Buren, Kristen W ;

Rocheleau, Carissa M

July 2025 | Occupational and Environmental Medicine, 2025, v. 82, no. 5

We investigated associations between occupational noise and gestational diabetes mellitus, pregnancy-related hypertension (including pre-eclampsia/eclampsia), preterm birth and small for gestational age (SGA) infants.Data were analysed for 7889 singleton, live-born infants without major birth defects or chromosomal disorders and their mothers from ...

10/09/2026

Supporting Files

Title : Maternal Occupational Exposure to Noise: Prevalence, Maternal Effects and Infant Outcomes in the National Birth Defects Prevention Study, 1997-2011. Personal Author(s) : Van Buren, Kristen W;Rocheleau, Carissa M;Chen, I-Chen;Sanderson, Wayne T;MacDonald, Leslie A;Masterson, Elizabeth A;Nestoridi, Eirini;Ailes, Elizabeth C; Corporate Authors(s) : the National Birth Defects Prevention Study Published Date : July 2025 Pages in Document : 222-229 (17 pdf pages) Source : Occupational and Environmental Medicine, 2025, v. 82, no. 5 DOI : https://doi.org/10.1136/oemed-2024-109928 Journal Title : Occupational and Environmental Medicine
Van Buren, K. W., Rocheleau, C. M., Chen, I. C., Sanderson, W. T., MacDonald, L. A., Masterson, E. A., Nestoridi, E., & Ailes, E. C. (2025). Maternal Occupational Exposure to Noise: Prevalence, Maternal Effects and Infant Outcomes in the National Birth Defects Prevention Study, 1997-2011. Occupational and Environmental Medicine, 82(5). https://doi.org/10.1136/oemed-2024-109928

Van Buren, Kristen W, Carissa M Rocheleau, I-Chen Chen, Wayne T Sanderson, Leslie A MacDonald, Elizabeth A Masterson, Eirini Nestoridi, and Elizabeth C Ailes. "Maternal Occupational Exposure to Noise: Prevalence, Maternal Effects and Infant Outcomes in the National Birth Defects Prevention Study, 1997-2011." Occupational and Environmental Medicine 82, no. 5 (2025). https://doi.org/10.1136/oemed-2024-109928.

Van Buren, Kristen W, et al. "Maternal Occupational Exposure to Noise: Prevalence, Maternal Effects and Infant Outcomes in the National Birth Defects Prevention Study, 1997-2011." Occupational and Environmental Medicine, vol. 82, no. 5, 2025. Stacks. https://doi.org/10.1136/oemed-2024-109928.
Export RIS Citation Information. TY - Journal Article AU - Van Buren, Kristen W AU - Rocheleau, Carissa M AU - Chen, I-Chen AU - Sanderson, Wayne T AU - MacDonald, Leslie A AU - Masterson, Elizabeth A AU - Nestoridi, Eirini AU - Ailes, Elizabeth C A2 - the National Birth Defects Prevention Study AB - We investigated associations between occupational noise and gestational diabetes mellitus, pregnancy-related hypertension (including pre-eclampsia/eclampsia), preterm birth and small for gestational age (SGA) infants. AB - Data were analysed for 7889 singleton, live-born infants without major birth defects or chromosomal disorders and their mothers from the National Birth Defects Prevention Study from 1997 to 2011. Typical maternal occupational noise exposure in all jobs held from 1 month prior to conception through the end of pregnancy was estimated by expert rater and categorised as quiet (<60 A-weighted decibels (dBA)), low (60-75 dBA), moderate (76-84 dBA) or loud (>85 dBA). Multiple logistic regression was used to estimate associations (adjusted ORs and 95% CIs) between noise exposure levels and outcomes. AB - Approximately 77.4% of pregnant workers had quiet levels of occupational noise exposure, 11.0%, 10.1% and 1.5% had low, moderate and loud exposure levels, respectively. Compared with quiet levels of noise, pregnant workers exposed to low levels of noise had decreased odds of delivering an SGA infant (adjusted OR (aOR)=0.72; 95% CI 0.53 to 0.99) and those exposed to moderate levels had increased odds of delivering an SGA infant (aOR=1.37; 95% CI 1.05 to 1.77). No other significant associations were observed. AB - Maternal occupational noise exposure below the 85 dBA threshold recognised as hazardous may be associated with SGA among infants. Elevated point estimates (>1) were observed for the highest noise exposure category and all outcomes, though CIs were wide and statistical significance was not attained. Further research is warranted to address existing knowledge gaps. AB - Author manuscript AN - cdc:261270 C4 - PMC12362229 DO - https://doi.org/10.1136/oemed-2024-109928 IS - 5 J2 - Occupational and Environmental Medicine KW - Occupational Exposure KW - Pregnancy KW - Premature Birth KW - Female KW - Diabetes, Gestational KW - Infant, Newborn KW - Young Adult KW - Logistic Models KW - Congenital Abnormalities KW - Infant, Small for Gestational Age KW - Pre-Eclampsia KW - Maternal Exposure KW - Prevalence KW - Humans KW - Pregnancy Outcome KW - Adult KW - Noise, Occupational KW - Hypertension, Pregnancy-Induced KW - Humans KW - Female KW - Pregnancy KW - Noise, Occupational KW - Adult KW - Maternal Exposure KW - Infant, Newborn KW - Infant, Small for Gestational Age KW - Occupational Exposure KW - Premature Birth KW - Prevalence KW - Diabetes, Gestational KW - Young Adult KW - Hypertension, Pregnancy-Induced KW - Pregnancy Outcome KW - Logistic Models KW - Congenital Abnormalities KW - Pre-Eclampsia LA - eng PY - 2025 T2 - Occupational and Environmental Medicine T2 - Occupational and Environmental Medicine, 2025, v. 82, no. 5 TI - Maternal Occupational Exposure to Noise: Prevalence, Maternal Effects and Infant Outcomes in the National Birth Defects Prevention Study, 1997-2011. VL - 82 UR - https://stacks.cdc.gov/view/cdc/261270 ER -
Implementation Evaluation of Three Community-Clinical Infection-Related Cancer Prevention and Control Programs in New York City: Lessons Learned From Leveraging Community Health Worker Strategies to Enhance Reach and Fit For Asian American Communiti

Lee, Matthew ;

Kranick, Julie

July 2026 | Community Health Equity Research & Policy, 2026, v. 46, no. 4

BackgroundCommunity health workers (CHW) can perform unique functions to facilitate the implementation of evidence-based interventions for infection-related cancer prevention and control, and alleviate minoritized and immigration-related disparities.PurposeWe describe the implementation evaluation of three CHW-delivered infection-related cancer pro ...

10/09/2026

Supporting Files

Title : Implementation Evaluation of Three Community-Clinical Infection-Related Cancer Prevention and Control Programs in New York City: Lessons Learned From Leveraging Community Health Worker Strategies to Enhance Reach and Fit For Asian American Communiti Personal Author(s) : Lee, Matthew;Kranick, Julie;Foster, Victoria;Chebli, Perla;Yusuf, Yousra;Trinh-Shevrin, Chau;Kwon, Simona C.; Published Date : July 2026 Pages in Document : 445-453 (12 pdf pages) Source : Community Health Equity Research & Policy, 2026, v. 46, no. 4 DOI : https://doi.org/10.1177/2752535X251357464 Journal Title : Community Health Equity Research & Policy
Lee, M., Kranick, J., Foster, V., Chebli, P., Yusuf, Y., Trinh-Shevrin, C., & Kwon, S. C. (2026). Implementation Evaluation of Three Community-Clinical Infection-Related Cancer Prevention and Control Programs in New York City: Lessons Learned From Leveraging Community Health Worker Strategies to Enhance Reach and Fit For Asian American Communiti. Community Health Equity Research & Policy, 46(4). https://doi.org/10.1177/2752535X251357464

Lee, Matthew, Julie Kranick, Victoria Foster, Perla Chebli, Yousra Yusuf, Chau Trinh-Shevrin, and Simona C. Kwon. "Implementation Evaluation of Three Community-Clinical Infection-Related Cancer Prevention and Control Programs in New York City: Lessons Learned From Leveraging Community Health Worker Strategies to Enhance Reach and Fit For Asian American Communiti." Community Health Equity Research & Policy 46, no. 4 (2026). https://doi.org/10.1177/2752535X251357464.

Lee, Matthew, et al. "Implementation Evaluation of Three Community-Clinical Infection-Related Cancer Prevention and Control Programs in New York City: Lessons Learned From Leveraging Community Health Worker Strategies to Enhance Reach and Fit For Asian American Communiti." Community Health Equity Research & Policy, vol. 46, no. 4, 2026. Stacks. https://doi.org/10.1177/2752535X251357464.
Export RIS Citation Information. TY - Journal Article AU - Lee, Matthew AU - Kranick, Julie AU - Foster, Victoria AU - Chebli, Perla AU - Yusuf, Yousra AU - Trinh-Shevrin, Chau AU - Kwon, Simona C. AB - BackgroundCommunity health workers (CHW) can perform unique functions to facilitate the implementation of evidence-based interventions for infection-related cancer prevention and control, and alleviate minoritized and immigration-related disparities.PurposeWe describe the implementation evaluation of three CHW-delivered infection-related cancer programs focused on Asian American (AA) communities in New York City: 1) a H. pylori treatment adherence program for Chinese and Korean Americans; 2) a HPV screening program for Muslim Americans; and 3) a hepatitis B screening, linkage to care, and treatment program for AA and other priority communities.MethodsWe conducted semi-structured key informant interviews with multi-level stakeholders from the programs.ResultsLessons learned include the importance of: 1) sustaining engagement and buy-in from implementation partners; 2) prioritizing recipient- and deliverer-centeredness; 3) fostering program flexibility to accommodate multiple implementation settings and to meet dynamic community resources and priorities; and 4) understanding interoperability between the CHW-delivered intervention and the inner setting for effective program implementation.ConclusionsThese findings can inform other efforts to implement CHW-delivered community-clinical cancer programs for AA and other underserved communities to advance health equity. AB - Author manuscript AN - cdc:261269 C4 - PMC12383678 DO - https://doi.org/10.1177/2752535X251357464 IS - 4 J2 - Community Health Equity Research & Policy KW - Female KW - Papillomavirus Infections KW - Community Health Workers KW - Neoplasms KW - Hepatitis B KW - Male KW - Program Evaluation KW - Humans KW - Asian KW - Humans KW - Community Health Workers KW - Asian KW - Neoplasms KW - Program Evaluation KW - Female KW - Male KW - Papillomavirus Infections KW - Hepatitis B LA - eng PY - 2026 T2 - Community Health Equity Research & Policy T2 - Community Health Equity Research & Policy, 2026, v. 46, no. 4 TI - Implementation Evaluation of Three Community-Clinical Infection-Related Cancer Prevention and Control Programs in New York City: Lessons Learned From Leveraging Community Health Worker Strategies to Enhance Reach and Fit For Asian American Communiti VL - 46 UR - https://stacks.cdc.gov/view/cdc/261269 ER -
Transformative Potential of Artificial Intelligence in US CDC HIV Interventions: Balancing Innovation With Health Privacy.

Kamitani, Emiko ;

Koenig, Linda J.

August 2025 | AIDS (London, England), 2025, v. 39, no. 10

Artificial intelligence (AI) holds significant potential to transform HIV prevention and treatment through the application of advanced technologies such as machine learning (ML), deep learning (DL), and generative AI (Gen AI). These technologies can enhance the monitoring, management, and analysis of vast and complex HIV-related datasets, enabling ...

10/09/2026

Supporting Files

Title : Transformative Potential of Artificial Intelligence in US CDC HIV Interventions: Balancing Innovation With Health Privacy. Personal Author(s) : Kamitani, Emiko;Koenig, Linda J.;Sullivan, Patrick; Published Date : August 2025 Pages in Document : 1311-1321 (18 pdf pages) Source : AIDS (London, England), 2025, v. 39, no. 10 DOI : https://doi.org/10.1097/QAD.0000000000004220 Journal Title : AIDS (London, England)
Kamitani, E., Koenig, L. J., & Sullivan, P. (2025). Transformative Potential of Artificial Intelligence in US CDC HIV Interventions: Balancing Innovation With Health Privacy. AIDS (London, England), 39(10). https://doi.org/10.1097/QAD.0000000000004220

Kamitani, Emiko, Linda J. Koenig, and Patrick Sullivan. "Transformative Potential of Artificial Intelligence in US CDC HIV Interventions: Balancing Innovation With Health Privacy." AIDS (London, England) 39, no. 10 (2025). https://doi.org/10.1097/QAD.0000000000004220.

Kamitani, Emiko, et al. "Transformative Potential of Artificial Intelligence in US CDC HIV Interventions: Balancing Innovation With Health Privacy." AIDS (London, England), vol. 39, no. 10, 2025. Stacks. https://doi.org/10.1097/QAD.0000000000004220.
Export RIS Citation Information. TY - Journal Article AU - Kamitani, Emiko AU - Koenig, Linda J. AU - Sullivan, Patrick AB - Artificial intelligence (AI) holds significant potential to transform HIV prevention and treatment through the application of advanced technologies such as machine learning (ML), deep learning (DL), and generative AI (Gen AI). These technologies can enhance the monitoring, management, and analysis of vast and complex HIV-related datasets, enabling more timely predictions of potential risks and improving HIV care strategies. AI is poised to streamline HIV prevention interventions by increasing workforce efficiency, supporting expanded accessibility and sustainability of preexposure prophylaxis (PrEP) care in nontraditional settings, and supporting clinical decision-making. Additionally, when utilized within HIV care systems, AI can help close gaps in diagnosis, treatment, and continuous care engagement. However, to optimize AI's potential in HIV prevention, careful implementation is crucial. Challenges such as reducing bias, ensuring ethical standards (including health privacy standards) are maintained, and mitigating risks like AI hallucinations must be addressed. Thoughtful integration, community consultation, and continuous evaluation will be critical to ensuring that AI plays a beneficial role in HIV prevention and drives innovations that lead to more equitable health outcomes. This editorial review explores AI's transformative potential, focusing on the US CDC's key public health strategies for HIV prevention. When aligning with public health strategies - particularly in countries supported by initiatives like President's Emergency Plan for AIDS Relief (PEPFAR) - AI can contribute significantly to global efforts to end the HIV epidemic. It offers a vision for AI's future application in HIV prevention, emphasizing the need for a holistic and syndemic approach to improving HIV prevention worldwide. AB - Author manuscript AN - cdc:261268 C4 - PMC12409397 DO - https://doi.org/10.1097/QAD.0000000000004220 IS - 10 J2 - AIDS (London, England) KW - Artificial Intelligence KW - Humans KW - Centers for Disease Control and Prevention, U.S. KW - HIV Infections KW - Pre-Exposure Prophylaxis KW - HIV KW - artificial intelligence KW - machine learning KW - deep learning KW - public health KW - Humans KW - Artificial Intelligence KW - Centers for Disease Control and Prevention, U.S. KW - HIV Infections KW - Pre-Exposure Prophylaxis LA - eng PY - 2025 T2 - AIDS (London, England) T2 - AIDS (London, England), 2025, v. 39, no. 10 TI - Transformative Potential of Artificial Intelligence in US CDC HIV Interventions: Balancing Innovation With Health Privacy. VL - 39 UR - https://stacks.cdc.gov/view/cdc/261268 ER -
Bordetella Pertussis Infection and Antibody Dynamics in Household Cohorts in Two South African Communities, 2016 - 2018: Findings From the PHIRST Study.

Moosa, Fahima ;

Kleynhans, Jackie

August 2025 | The Journal of Infection, 2025, v. 91, no. 2

In a cohort study, enrolling new households annually during 2016-2018, we estimated the B. pertussis attack rate using serology and PCR, identified factors associated with seroconversion, and described antibody changes over time. Nasopharyngeal swabs were collected biweekly for 6-10 months annually, with cases defined as individuals testing PCR-pos ...

10/09/2026

Supporting Files

Title : Bordetella Pertussis Infection and Antibody Dynamics in Household Cohorts in Two South African Communities, 2016 - 2018: Findings From the PHIRST Study. Personal Author(s) : Moosa, Fahima;Kleynhans, Jackie;Makhathini, Lillian;du Plessis, Mignon;Tempia, Stefano;McMorrow, Meredith L.;Moyes, Jocelyn;Buys, Amelia;Maake, Lorens;Smit, Sheilagh;Martinson, Neil A.;Kahn, Kathleen;Lebina, Limakatso;Cohen, Cheryl;von Gottberg, Anne;Wolter, Nicole; Published Date : August 2025 Pages in Document : 106550 (25 pdf pages) Source : The Journal of Infection, 2025, v. 91, no. 2 DOI : https://doi.org/10.1016/j.jinf.2025.106550 Journal Title : The Journal of Infection
Moosa, F., Kleynhans, J., Makhathini, L., du Plessis, M., Tempia, S., McMorrow, M. L., Moyes, J., Buys, A., Maake, L., Smit, S., Martinson, N. A., Kahn, K., Lebina, L., Cohen, C., von Gottberg, A., & Wolter, N. (2025). Bordetella Pertussis Infection and Antibody Dynamics in Household Cohorts in Two South African Communities, 2016 - 2018: Findings From the PHIRST Study. The Journal of Infection, 91(2). https://doi.org/10.1016/j.jinf.2025.106550

Moosa, Fahima, Jackie Kleynhans, Lillian Makhathini, Mignon du Plessis, Stefano Tempia, Meredith L. McMorrow, and Jocelyn Moyes, et al.. "Bordetella Pertussis Infection and Antibody Dynamics in Household Cohorts in Two South African Communities, 2016 - 2018: Findings From the PHIRST Study." The Journal of Infection 91, no. 2 (2025). https://doi.org/10.1016/j.jinf.2025.106550.

Moosa, Fahima, et al. "Bordetella Pertussis Infection and Antibody Dynamics in Household Cohorts in Two South African Communities, 2016 - 2018: Findings From the PHIRST Study." The Journal of Infection, vol. 91, no. 2, 2025. Stacks. https://doi.org/10.1016/j.jinf.2025.106550.
Export RIS Citation Information. TY - Journal Article AU - Moosa, Fahima AU - Kleynhans, Jackie AU - Makhathini, Lillian AU - du Plessis, Mignon AU - Tempia, Stefano AU - McMorrow, Meredith L. AU - Moyes, Jocelyn AU - Buys, Amelia AU - Maake, Lorens AU - Smit, Sheilagh AU - Martinson, Neil A. AU - Kahn, Kathleen AU - Lebina, Limakatso AU - Cohen, Cheryl AU - von Gottberg, Anne AU - Wolter, Nicole AB - In a cohort study, enrolling new households annually during 2016-2018, we estimated the B. pertussis attack rate using serology and PCR, identified factors associated with seroconversion, and described antibody changes over time. Nasopharyngeal swabs were collected biweekly for 6-10 months annually, with cases defined as individuals testing PCR-positive at least once. Seroconversion was defined as a ≥4-fold increase in anti-pertussis toxin IgG concentration between consecutive blood draws. Logistic regression was used to identify factors associated with seroconversion among PCR-positive individuals. AB - Among 1509 participants, the serology attack rate was 5.8% (87/1509), 6.2% (94/1509) by PCR, and 9.6% (145/1509) combining both methods. Among PCR-positive cases, 38.3% (36/94) seroconverted, with a mean time to seroconversion of 2.9 months (range: 3 weeks-5.9 months). Younger participants (5-18 years) (adjusted odds ratio (aOR) 6.8, 95% confidence interval (CI) 1.3-35.1) and those with episode durations of ≥7 days (aOR 13.3, 95% CI 3.4-51.1) were more likely to seroconvert. Among the seroconverted, 75.0% (27/36) maintained antibody concentrations >40 IU/ml for at least 12 months post-infection. AB - Almost 10% of participants had B. pertussis infection during follow-up. Less than half of individuals with PCR-confirmed infection seroconverted but maintained elevated antibodies for at least one-year post-infection. AB - Author manuscript AN - cdc:261267 C4 - PMC12477660 DO - https://doi.org/10.1016/j.jinf.2025.106550 IS - 2 J2 - The Journal of Infection KW - Adolescent KW - Female KW - Antibodies, Bacterial KW - Polymerase Chain Reaction KW - Nasopharynx KW - Family Characteristics KW - Whooping Cough KW - Young Adult KW - Immunoglobulin G KW - Child KW - Cohort Studies KW - Pertussis Toxin KW - Infant KW - Seroconversion KW - Male KW - Bordetella pertussis KW - Middle Aged KW - Humans KW - Child, Preschool KW - Adult KW - B. pertussis KW - Real-time PCR KW - ELISA KW - Seroconversion KW - Anti-PT IgG KW - Antibodies KW - Antibody dynamics KW - Humans KW - Whooping Cough KW - Male KW - Female KW - Bordetella pertussis KW - Antibodies, Bacterial KW - Child, Preschool KW - Adult KW - Adolescent KW - Cohort Studies KW - Child KW - Immunoglobulin G KW - Young Adult KW - Infant KW - Seroconversion KW - Family Characteristics KW - Middle Aged KW - Nasopharynx KW - Pertussis Toxin KW - Polymerase Chain Reaction LA - eng PY - 2025 T2 - The Journal of Infection T2 - The Journal of Infection, 2025, v. 91, no. 2 TI - Bordetella Pertussis Infection and Antibody Dynamics in Household Cohorts in Two South African Communities, 2016 - 2018: Findings From the PHIRST Study. VL - 91 UR - https://stacks.cdc.gov/view/cdc/261267 ER -

Previous Page Previous

1121 - 1140 / 1999

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov